Arcturus Therapeutics, CureVac Announce Collaboration

The companies' first joint therapy will target a genetic disease marked by ammonia accumulating in the blood.

Illumina, KingMed Partner to Develop Sequencing Technology for China

Illumina called the collaboration a “significant step” toward China Food and Drug Administration review and approval.

Look Ahead: Illumina Aims to Be ‘More Clinical, More Global, and More Digital’

After dominating the research market, genomics giant Illumina set its sights on clinics.

Tease photo

Look Ahead: NuVasive Set to Expand Its Footprint, Increase Its Staff

NuVasive is poised to keep expanding into 2018, from its balance sheet to its headquarters.

Tease photo

Former Receptos Executives Launch New Co. With $100M

Faheem Hasnain and Sheila Gujrathi — former executives of Receptos — have launched a new San Diego biopharmaceutical company...

Medtech Cos. Look to Derail Device Tax

LAW: Cos. Claim ACA Tax Damages Hiring and R&D

Carlsbad’s Ra Medical Systems is among the medtech companies that say the return of a 2.3 percent excise tax on medical devices sold in the U.S. threatens expansion and hiring plans.

Tease photo

Big VC Backing Gets Behind Biotech’s Portfolio of Small Molecule Drugs

Expansion Therapeutics was incubated within life science venture capital firm 5AM Ventures’ 4:59 Initiative.

Tandem Diabetes Care Increases S.D. Manufacturing Space

The company’s new 50,000-square-foot facility on Barnes Canyon Road recently became fully operational.

Cannabis-Derived Drug Granted Priority Review

Greenwich Biosciences developed epidolex, a treatment for seizures in two rare, severe childhood-onset epilepsy disorders.

Organovo’s 3D Bioprinted Tissue Treatment Receives Orphan Drug Designation

Organovo designs and creates functional, three-dimensional human tissues for use in drug discovery, clinical development and therapeutic applications.

2017 Newsmakers: Tocagen Advances Cancer Fight with IPO, Breakthrough Designation

2017 Newsmakers

Tocagen brought on Martin “Marty” Duvall as CEO more than a year ago to commercialize its anti-cancer therapies. In 2017, the company marked several milestones on that front.

Tease photo

2017 Newsmakers: Hemker Exits After Huge Changes at Palomar Health

2017 Newsmakers

Robert Hemker, long an architect of Palomar Health District’s financial plans, retired in November.

Tease photo

Palomar Health Nurses, Caregivers Ratify 4-Year Contracts

Under the agreements, 3,000 employees received a retroactive pay raise.

Batu Biologics Raises $1.3M in Equity Crowdfunding Offering

The proceeds of this offering were initially earmarked for investigational new drug-enabling experiments.

Roche Buys S.D. Drugmaker Ignyta for $1.7B

The pharma giant is betting on Ignyta's cancer drug, entrectinib, which is intended to treat patients with rare cancers.

Tease photo